NCT07140848 CGM-Enhanced DPP to Prevent Type 2 Diabetes in Adults With Prediabetes
| NCT ID | NCT07140848 |
| Status | Recruiting |
| Phase | — |
| Sponsor | State University of New York at Buffalo |
| Condition | PreDiabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 214 participants |
| Start Date | 2026-04-13 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 214 participants in total. It began in 2026-04-13 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prediabetes affects over one-third of adults in the United States, placing them at a higher risk for developing type 2 diabetes and heart disease, which can lead to serious health complications and increased medical costs. Although a program called the Diabetes Prevention Program (DPP) has been shown to lower the risk of diabetes through healthy lifestyle changes, many people find it difficult to stick with these changes over the long term. This study seeks to find out if combining DPP coaching with continuous glucose monitoring (CGM) technology can help people stay on track with their health goals.
Eligibility Criteria
Inclusion Criteria: 1. adults aged 18 years or older, 2. diagnosis of prediabetes, as defined by current clinical guidelines (HbA1c 5.7% to 6.4%, fasting plasma glucose 100-125 mg/dL, or 2-hour plasma glucose 140-199 mg/dL following a 75g oral glucose tolerance test), 3. body mass index (BMI) of at least 24 kg/m² (or 22 kg/m² for Asian Americans), 4. willingness to comply with all aspects of the study protocol, including attending coaching sessions and using CGM devices. Exclusion Criteria: Individuals will be excluded from the study if they 1. have a diagnosis of type 1 or type 2 diabetes, 2. are currently using CGMs or have medical contraindications to CGM use, such as severe skin allergies or implantable defibrillators, or 3. are currently enrolled in another clinical trial for prediabetes. Additionally, using validated assessments, we will exclude participants with significant dementia, alcohol or drug abuse/dependency, active psychosis, or life expectancy less than 12 months as these conditions are likely to interfere with adherence to the intervention.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07140848 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PreDiabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07140848 currently recruiting?
Yes, NCT07140848 is actively recruiting participants. Contact the research team at rfraser@buffalo.edu for enrollment information.
Where is the NCT07140848 trial being conducted?
This trial is being conducted at Buffalo, United States.
Who is sponsoring the NCT07140848 clinical trial?
NCT07140848 is sponsored by State University of New York at Buffalo. The trial plans to enroll 214 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.